Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.

Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Jones RN.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):252-9. doi: 10.1016/j.diagmicrobio.2011.07.007. Epub 2011 Sep 13.

PMID:
21917395
2.

Detecting drug-resistant tuberculosis: the importance of rapid testing.

Hoek KG, Van Rie A, van Helden PD, Warren RM, Victor TC.

Mol Diagn Ther. 2011 Aug 1;15(4):189-94. doi: 10.2165/11593780-000000000-00000.

PMID:
21913741
3.

Evaluation of disk approximation and single-well broth tests for detection of inducible clindamycin resistance in Streptococcus pneumoniae.

Jorgensen JH, McElmeel ML, Fulcher LC, McGee L, Glennen A.

J Clin Microbiol. 2011 Sep;49(9):3332-3. doi: 10.1128/JCM.00960-11. Epub 2011 Jul 20.

4.

Macrolide resistance in Mycoplasma pneumoniae, Israel, 2010.

Averbuch D, Hidalgo-Grass C, Moses AE, Engelhard D, Nir-Paz R.

Emerg Infect Dis. 2011 Jun;17(6):1079-82. doi: 10.3201/eid/1706.101558.

5.

Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.

Richter SS, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Kroeger JS, Biek D, Critchley IA, Diekema DJ, Doern GV.

Antimicrob Agents Chemother. 2011 Sep;55(9):4154-60. doi: 10.1128/AAC.00315-11. Epub 2011 Jun 27.

6.

Evaluation of GeneOhm VanR and Xpert vanA/vanB molecular assays for the rapid detection of vancomycin-resistant enterococci.

Gazin M, Lammens C, Goossens H, Malhotra-Kumar S; MOSAR WP2 Study Team.

Eur J Clin Microbiol Infect Dis. 2012 Mar;31(3):273-6. doi: 10.1007/s10096-011-1306-y. Epub 2011 Jun 12.

PMID:
21667270
7.

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria.

Pfaller MA, Andes D, Arendrup MC, Diekema DJ, Espinel-Ingroff A, Alexander BD, Brown SD, Chaturvedi V, Fowler CL, Ghannoum MA, Johnson EM, Knapp CC, Motyl MR, Ostrosky-Zeichner L, Walsh TJ.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):330-43. doi: 10.1016/j.diagmicrobio.2011.03.002. Epub 2011 May 4. Review.

PMID:
21546199
8.

Multicenter comparison of the Vitek 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing caspofungin, micafungin, and posaconazole against Candida spp.

Peterson JF, Pfaller MA, Diekema DJ, Rinaldi MG, Riebe KM, Ledeboer NA.

J Clin Microbiol. 2011 May;49(5):1765-71. doi: 10.1128/JCM.02517-10. Epub 2011 Mar 23.

9.

Diagnostic accuracy of the Cepheid GeneXpert vanA/vanB assay ver. 1.0 to detect the vanA and vanB vancomycin resistance genes in Enterococcus from perianal specimens.

Marner ES, Wolk DM, Carr J, Hewitt C, Dominguez LL, Kovacs T, Johnson DR, Hayden RT.

Diagn Microbiol Infect Dis. 2011 Apr;69(4):382-9. doi: 10.1016/j.diagmicrobio.2010.11.005.

PMID:
21396533
10.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Pfaller MA, Diekema DJ, Andes D, Arendrup MC, Brown SD, Lockhart SR, Motyl M, Perlin DS; CLSI Subcommittee for Antifungal Testing.

Drug Resist Updat. 2011 Jun;14(3):164-76. doi: 10.1016/j.drup.2011.01.004. Epub 2011 Feb 24. Review.

PMID:
21353623
12.

Antimicrobial-resistant nocardia isolates, United States, 1995-2004.

Uhde KB, Pathak S, McCullum I Jr, Jannat-Khah DP, Shadomy SV, Dykewicz CA, Clark TA, Smith TL, Brown JM.

Clin Infect Dis. 2010 Dec 15;51(12):1445-8. doi: 10.1086/657399. Epub 2010 Nov 8.

PMID:
21058914
13.

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods.

Pfaller MA, Andes D, Diekema DJ, Espinel-Ingroff A, Sheehan D; CLSI Subcommittee for Antifungal Susceptibility Testing.

Drug Resist Updat. 2010 Dec;13(6):180-95. doi: 10.1016/j.drup.2010.09.002. Epub 2010 Nov 2. Review.

PMID:
21050800
14.

Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nocardia species.

Verroken A, Janssens M, Berhin C, Bogaerts P, Huang TD, Wauters G, Glupczynski Y.

J Clin Microbiol. 2010 Nov;48(11):4015-21. doi: 10.1128/JCM.01234-10. Epub 2010 Sep 22.

15.

Evaluation of BBL CHROMagar VanRE for detection of vancomycin-resistant Enterococci in rectal swab specimens.

Stamper PD, Shulder S, Bekalo P, Manandhar D, Ross TL, Speser S, Kingery J, Carroll KC.

J Clin Microbiol. 2010 Nov;48(11):4294-7. doi: 10.1128/JCM.01522-10. Epub 2010 Aug 25.

16.

High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.

Cao B, Zhao CJ, Yin YD, Zhao F, Song SF, Bai L, Zhang JZ, Liu YM, Zhang YY, Wang H, Wang C.

Clin Infect Dis. 2010 Jul 15;51(2):189-94. doi: 10.1086/653535.

PMID:
20540621
17.

Staphylococcus aureus: An old pathogen with new weapons.

Tang YW, Stratton CW.

Clin Lab Med. 2010 Mar;30(1):179-208. doi: 10.1016/j.cll.2010.01.005. Review.

PMID:
20513547
18.

Detection of inducible clindamycin resistance in beta-hemolytic streptococci by using the CLSI broth microdilution test and erythromycin-clindamycin combinations.

Bowling JE, Owens AE, McElmeel ML, Fulcher LC, Herrera ML, Wickes BL, Jorgensen JH.

J Clin Microbiol. 2010 Jun;48(6):2275-7. doi: 10.1128/JCM.00663-10. Epub 2010 Apr 14.

19.

Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.

Martos AI, Romero A, González MT, González A, Serrano C, Castro C, Pemán J, Cantón E, Martín-Mazuelos E.

Med Mycol. 2010 Sep;48(6):858-61. doi: 10.3109/13693781003586943.

PMID:
20144131
20.

Increase in pneumococcus macrolide resistance, United States.

Jenkins SG, Farrell DJ.

Emerg Infect Dis. 2009 Aug;15(8):1260-4. doi: 10.3201/eid1508.081187.

Supplemental Content

Support Center